Hospira Docetaxel Injection, 120 mg/12 mL, single vial

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

docetaxel, Quantity: 10 mg/mL

から入手可能:

Hospira Australia Pty Ltd

INN（国際名）:

Docetaxel

医薬品形態:

Injection

構図:

Excipient Ingredients: citric acid; ethanol absolute; polysorbate 80; polyethylene glycol monomethyl ether

投与経路:

Intravenous Infusion

パッケージ内のユニット:

1 x 15 mL vial

処方タイプ:

(S1) This Schedule is intentionally blank

適応症:

Breast cancer, Non-small cell lung cancer, Stomach cancer, Head and neck cancer, Ovarian cancer, Oesophageal cancer, Uterine cancer, Prostate cancer

製品概要:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

認証ステータス:

Licence status A

承認日:

2013-10-25